<DOC>
	<DOCNO>NCT02842723</DOCNO>
	<brief_summary>Prospective , open label , phase II , monocenter trial combine partial surgery resection protontherapy management paediatric craniopharyngioma .</brief_summary>
	<brief_title>Management Pediatric Craniopharyngioma Combination Partial Surgical Resection , Protontherapy ( Craniopharyngioma )</brief_title>
	<detailed_description>This study phase II prospective , open label , phase ii , monocenter . The main objective evaluate fractionate high precision radiotherapy dose 59,5 Gy ( 1,7 Gy daily , 5 fraction per week ) .</detailed_description>
	<mesh_term>Craniopharyngioma</mesh_term>
	<mesh_term>Adamantinoma</mesh_term>
	<criteria>Histologically document craniopharyngioma Age range 3 16 year Landsky performance status &gt; 60 Incomplete surgical resection simple biopsy Solid and/or cystic aspect image Irradiation perform time presentation local progression Signed informed consent parent legal representative ( copy participate center ) Previous history radiotherapy ( include stereotactic ) administer head neck region Severe vasculopathy Participation concurrent study Contraindication general anesthesia child 5 year Patient noncompliant minimum 30 mn immobilisation Patient deprive freedom guardianship Patient expect follow long run</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>craniopharyngioma</keyword>
	<keyword>protontherapy</keyword>
</DOC>